Back
Protagenic Therapeutics, Inc. 10K Form
Sell
1
PTIX
Protagenic Therapeutics, Inc.
Last Price:
$1.23
Seasonality Move:
-0.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PTIX News And Ratings
See the #1 stock for the next 7 days that we like better than PTIX
PTIX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.43 |
| Price / Book: | 1.61 |
Profitability
| EPS (TTM): | -7.93540 |
|---|---|
| Net Income (TTM): | $-8.9M |
| Gross Margin: | $-50.3K |
| Return on Equity: | 0% |
| Return on Assets: | -279.76% |
Protagenic Therapeutics, Inc. Earnings Forecast
Key Protagenic Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 25 years have been positive in 11 years.
Protagenic Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PTIX |
| Website: | protagenic.com |
Debt
| Debt-to-Equity Ratio: | -0.85 |
|---|---|
| Current Ratio: | 0.29 |
| Quick Ratio: | 0.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PTIX Technical Analysis vs Fundamental Analysis
Sell
1
Protagenic Therapeutics, Inc. (PTIX)
is a Sell
Is Protagenic Therapeutics, Inc. a Buy or a Sell?
-
Protagenic Therapeutics, Inc. stock is rated a SellThe current Protagenic Therapeutics, Inc. [PTIX] share price is $1.19. The Score for PTIX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.